Weiguo Qing
Corporate Officer/Principal bij Hutchison MediPharma Ltd.
Profiel
Weiguo Qing is currently the Vice President & Head-Oncology Research at Hutchison MediPharma Ltd.
He previously worked as a Principal at Abbott Laboratories and Roche Corp.
He holds a doctorate degree from The University of Texas at Austin and a graduate degree from the Institute of Materia Medica.
Actieve functies van Weiguo Qing
| Bedrijven | Functie | Begin |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01-01-2008 |
Eerdere bekende functies van Weiguo Qing
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| Roche Corp. | Corporate Officer/Principal | - |
Opleiding van Weiguo Qing
| The University of Texas at Austin | Doctorate Degree |
| Institute of Materia Medica | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Corp. |
